Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual®): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequi

Authors

Yinjuan Li
Xinghe Wang (ORCID: https://orcid.org/0000-0002-4197-8545)
Lu Qi (ORCID: https://orcid.org/0009-0000-3792-7190)
H. Liu (ORCID: https://orcid.org/0009-0002-9358-7885)
Xiaoqiang Cheng
Yingjuan Zhang (ORCID: https://orcid.org/0000-0003-1849-7353)
Yingying Fang (ORCID: https://orcid.org/0000-0001-6334-8635)
Long Liu (ORCID: https://orcid.org/0000-0002-3473-2248)
Yu Wang (ORCID: https://orcid.org/0000-0001-9897-6412)
Qian Zhang (ORCID: https://orcid.org/0000-0002-7086-6606)
Yan Li (ORCID: https://orcid.org/0000-0003-0096-0813)
Ju Liu (ORCID: https://orcid.org/0000-0001-9932-2613)
Mingli Sun
Pu Li
Xiaoyun Liu
Chunyu Han

Institutions

Capital Medical University (CN)
Beijing Shijitan Hospital (CN)

Publication Details

Journal: Frontiers in Pharmacology
Published: 2025-08-28
DOI: https://doi.org/10.3389/fphar.2025.1631341
Primary Topic: Atrial Fibrillation Management and Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Clinical Trial Center, China Medical University Hospital

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual®): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequi

Yinjuan Li, Xinghe Wang, Lu Qi, H. Liu et al.

Aug 28, 2025

1 links

Frontiers in Pharmacology

Atrial Fibrillation Management and Outcomes

article

Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual®): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequi

Yinjuan Li, Xinghe Wang, Lu Qi, H. Liu, Xiaoqiang Cheng, Yingjuan Zhang, Yingying Fang, Long Liu, Yu Wang, Qian Zhang, Yan Li, Ju Liu, Mingli Sun, Pu Li, Xiaoyun Liu, Chunyu Han

August 28, 2025article en

Abstract

No abstract available for this paper.

Frontiers in PharmacologyVol. 16

Capital Medical University (CN), Beijing Shijitan Hospital (CN)

Clinical Trial Center, China Medical University Hospital

Openalex Percentile: Top 65%

Atrial Fibrillation Management and Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual®): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequi — Yinjuan Li, Xinghe Wang, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS